![Darren Keamy](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Darren Keamy
Director of Finance/CFO at
IMUGENE LIMITED
Net worth: 2 M $ as of 31/05/2026
Profile
Darren M.
Keamy currently works at Imugene Ltd., as Chief Financial Officer & Secretary from 2025.
Mr. Keamy also formerly worked at Clinuvel Pharmaceuticals Ltd., as Chief Financial Officer in 2024.
Mr. Keamy received his undergraduate degree from La Trobe University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 12/08/2025 | 242,890 ( 0.48% ) | 2 M $ | 31/05/2026 |
Darren Keamy active positions
| Companies | Position | Start |
|---|---|---|
| IMUGENE LIMITED | Director of Finance/CFO | 04/03/2025 |
Former positions of Darren Keamy
| Companies | Position | End |
|---|---|---|
| CLINUVEL PHARMACEUTICALS LIMITED | Director of Finance/CFO | 30/06/2024 |
Training of Darren Keamy
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
16
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Imugene Ltd.
 Imugene Ltd. BiotechnologyHealth Technology Operates as a a clinical stage immuno-oncology company | Health Technology |
Clinuvel Pharmaceuticals Ltd.
 Clinuvel Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products for patients with genetic, metabolic and life-threatening disorders | Health Technology |
LaTrobe University
 LaTrobe University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Darren Keamy
